EKF Diagnostics Holdings plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EKDHF research report →
About the company
EKF Diagnostics Holdings plc, a company founded in Cardiff, United Kingdom in 1990, specializes in the global design, development, manufacture, and sale of diagnostic instruments, reagents, and supporting products. Operating across Europe, the Middle East, the Americas, Asia, and Africa, the company offers a comprehensive range of solutions for clinical diagnostics. Their product line encompasses various diagnostic tools, including hemoglobin analyzers such as the hand-held DiaSpect Tm, DiaSpect Hemoglobin T, and the lab-quality Hemo Control, alongside the HemataStat II microhematocrit centrifuge.
- CEO
- Gavin Joseph Jones
- IPO
- 2014
- Employees
- 303
- HQ
- Cardiff, GB
Price Chart
- Market Cap
- $149.28M
- P/E
- 55.96
- P/S
- 2.19
- P/B
- 1.71
- EV/EBITDA
- 8.01
- Div Yield
- 0.00%
- Gross Margin
- 51.35%
- Op Margin
- 13.08%
- Net Margin
- 4.12%
- ROE
- 3.01%
- ROIC
- 3.25%
- Revenue
- $51.56M · 2.71%
- Net Income
- $2.12M · -66.01%
- EPS
- $0.00 · -65.94%
- Op Income
- $6.98M
- FCF YoY
- -28.35%
- 52W High
- $0.42
- 52W Low
- $0.29
- 50D MA
- $0.34
- 200D MA
- $0.35
- Beta
- 0.51
- Avg Volume
- 967
Get TickerSpark's AI analysis on EKDHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EKDHF coverage
Recent articles, reports, and earnings notes.
No research on EKDHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EKDHF report →Similar companies
Peers in the same neighborhood.